Abstract: Human cytomegalovirus (HCMV) gene expression during infection is characterized as a sequential process including immediate-early (IE), early (E), and late (L)-stage gene expression. The most abundantly expressed gene at the IE stage of infection is the major IE (MIE) gene that produces IE1 and IE2. IE1 has been the focus of study because it is an important protein, not only for viral gene expression but also for viral replication. It is believed that IE1 plays important roles in viral gene regulation by interacting with cellular proteins. In the current study, we performed protein array assays and identified 83 cellular proteins that interact with IE1. Among them, seven are RNA-binding proteins that are important in RNA processing; more than half are nuclear proteins that are involved in gene regulations. Tumorigenesis-related proteins are also found to interact with IE1, implying that the role of IE1 in tumorigenesis might need to be reevaluated. Unexpectedly, cytoplasmic proteins, such as Golgi autoantigen and GGA1 (both related to the Golgi trafficking protein), are also found to be associated with IE1. We also employed a coimmunoprecipitation assay to test the interactions of IE1 and some of the proteins identified in the protein array assays and confirmed that the results from the protein array assays are reliable. Many of the proteins identified by the protein array assay have not been previously reported. Therefore, the functions of the IE1-protein interactions need to be further explored in the future.
Introduction
Human cytomegalovirus (HCMV) has been defined as one of the major infectious agents related to AIDS. HCMV infects large populations in general and causes serious diseases in immunocompromised individuals [1] [2] [3] . A sequential process of viral events is characterized for CMV infection in permissive host cells [3] , including viral entry, immediate-early (IE) and early gene expression, DNA replication, late (L) gene expression, viral packaging and release. Major immediate-early (MIE) gene expression is one of the earliest events during CMV infection. MIE genes are the most abundantly expressed viral genes at the IE stage and give rise to several nuclear phosphoproteins that are critical for the next stage of gene expression and viral replication [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Hence, the HCMV MIE gene has been the focus of study. IE1 is believed to be the first de novo viral protein produced after HCMV infection and is essential for HCMV replication when HCMV is infected at a low multiplicity of infection (MOI).
In general, IE1 has been considered as a gene activator. How IE1 activates gene expression is not fully understood. Several mechanisms that are involved in this activation (by IE1) have been described by different groups. First, IE1 interacts with nuclear corepressors such as PML, Daxx, and Sp100, thereby reducing their repressive effects on gene expression [15, 16] . It was found by different groups independently that IE1 interacts with HDAC and inhibits HDAC's activity [15, 17] . Second, IE1 disperses ND10, a nuclear domain that contains many different nuclear suppressive proteins and responds to interferon stimulation [18] [19] [20] [21] . In addition, innate cellular defense directed by interferons was disrupted by IE1 via inhibiting JAK-STAT signaling and by interacting with STAT1 [22] [23] [24] . The IE1 protein counteracts virus-or type I IFN-induced ISG activation via complex formation with STAT1 and STAT2 resulting in the reduced binding of ISGF3 to ISREs [22] [23] [24] [25] . Last, IE1 is important for HCMV to arrest the cell cycle in the G1 phase that favors the infected HCMV for the cellular microenvironment. IE1 binds the Rb-related p107 protein and relieves its repression of E2F-responsive promoters [26] ; IE1 also induces p53 accumulation through activating the p53 pathway by increasing the levels of p19
Arf and by inducing the phosphorylation of p53 at Ser15 [27], which might also relate to the HCMV-caused "G1 arrest" of infected cells. The mechanisms used by IE1 to activate viral gene expression perhaps all depend on IE1-protein interactions. Therefore, it is important to identify the cellular proteins interacting with IE1 at a global level.
Results
One of the major challenges in the post-genomic era is to explore the functional elements in the human genome. It also applies to the virus-host interaction. Identifying the cellular proteins that interact with the important virus proteins will certainly contribute to the understanding of the mechanisms that the virus uses for its gene expression and replication. Protein arrays constitute a powerful tool for high throughput and multiplexed protein analysis, including protein detection, the investigation of protein interactions with various types of molecules, and the determination of protein functions [28] . Protein array technology is highly sensitive and generates large amounts of data in a single experiment with comparatively low sample consumption; therefore, it is highly economical [28] . In current studies, we used protein array assays to screen cellular proteins that interact with HCMV IE1. Here we report our experimental results.
First, we isolated the IE1 from an IE1-producing cell line (previously called U373-IE1, now called  U-251 MG-IE1) [29] using a specific anti-IE1 antibody that was later incubated with beads-conjugated secondary antibody after which the beads were washed in binding/wash buffer (20 mM Na 2 HPO 4 , 0.15 M NaCl, pH 7.0). The pulled-down IE1 was washed off from the secondary antibody-bound beads with elution buffer (0.1 M glycine, pH 2-3), and the eluted solution was immediately neutralized with neutralization buffer (1 M Tris, pH 8.5). The isolated IE1 was confirmed by Western blot assay as shown in the top of Figure 1 . Then the isolated IE1 was incubated at room temperature for 1 hour with the 22 cm × 22 cm PVDF membranes presenting up to 7390 in situ expressed human proteins (Cat# Unipex_1, _2, library # 9027, #9028, imaGenes GmbH, Berlin, Germany). After 24 h of incubation with primary anti-IE1 antibody at 4 °C, the membrane was washed with the buffer 2 times followed by incubation with a horseradish peroxidase-coupled secondary antibody (GE Healthcare Bio-Sciences, Pittsburgh, PA, USA) and detection with enhanced chemiluminescence (Pierce, Rockford, IL, USA), according to standard methods. As can be seen in Figure 1A ,B, 83 cellular proteins were found to bind to IE1. In the PVDF membrane, each in situ expressed cellular protein is presented in doublets, which is why we can see 2 dots together for each protein. We set up cutoffs according to the background index. Figure 1A ,B represents 2 PVDF membranes that were processed at the same time with the same samples. The 83 proteins are listed in the Table 1 with their Gene bank #, name, function, and references.
Further analysis of the 83 proteins revealed some important information: First, some of them have already been reported to interact with IE1. These are ATRX (#13) [15] , splicing factor, arginine/serine-rich 2 (#40) [18] , and Daxx (#65) [30] . Second, some of them are reported to be important for CMV infection but they have not been shown to interact with IE1, these are CDC25A (#10) [31] , ATF4 (#41) [32], BCL-2 (#46) [33] , and Ataxin (#39) [34] . In addition, 7 of the proteins that interact with IE1 are RNA binding proteins: RNA binding motif protein 10 (RBM10) (#5), RNA binding motif protein 5 (#20), Staufen, RNA binding protein (#26), splicing factor, arginine/serine-rich 2 (#40), heterogeneous nuclear ribonucleoprotein F (#52), RD RNA binding protein (#59), and PRP40 pre-mRNA processing factor 40 B (#60). All the RNA-bonding proteins are important for pre-mRNA processing. To our surprise, neither HDAC1, 2, or 3 nor TRIM19 (PML) is on the list; however, HDAC10 (#15) and TRIM33 (#57) are both detected as IE1-binding proteins with high signals (Figure 1 ).
Since most of the IE1-interacting proteins in the Table 1 have not been reported, we need to validate the reliability of the results from the protein arrays. For that purpose, we performed a coimmunoprecipitation (coIP) assay using antibodies on hand to examine whether the proteins can be pulled down by the anti-IE1 antibody. The IE1-producing cell line (U-251 MG-IE1) [29] was cultured at 37 °C until it reached 95% confluence. The nuclear extract was prepared according to the protocol as described in Material and Method section. The nuclear extracts were incubated with anti-IE1 antibody or with normal IgG and then secondary antibody-conjugated beads. After several washings, the eluted complexes from the beads were examined by Western blot assay using antibodies against the proteins as indicated in Figure 2 . All the proteins from the list that are examined by Western blot assay were positive. We also examined the tubulin as control and it was negative. Therefore, the results from the protein arrays are reliable. Figure 2 . Validation of some IE1 PPIs by coIP. The nuclear extract from the IE1-producing cell line was prepared and incubated with anti-IE1 antibody followed by incubation with secondary bound beads. The pulled-down complexes were examined by Western blot using antibodies against the protein, as indicated on the right hand side.
Discussion
HCMV infects a large part of the population and has serious consequences for immunocompromised persons with AIDS or who have received organ transplants and for newborns after congenital infection. In fact, HCMV is the leading viral cause of congenital birth defects [1]. More than 30% of primary HCMV infections in pregnant women result in placental transmission and clinical syndromes. Congenital infection is not uncommon [100] [101] [102] . Of symptomatic newborns, about 12% die and half of the survivors develop mental retardation, vision loss, and/or sensorineural deafness [103] . Interference strategies commonly target the early events of the replication cycle by using approved nucleoside analogs such as ganciclovir, the nucleotide analog cidofovir, and foscarnet. However, these can lead to resistance [104] . In vitro anti-sense oligonucleotides against the HCMV immediate-early protein 2 (IE2) have proven effective [105] , as has targeting the UL36 and UL37 sites [105, 106] . These attempts show that targeting the HCMV IE part of the propagation cycle may be effective; however, none of these treatments are permissible or feasible for use on a potentially infected fetus. The lack of suitable treatment modalities has especially serious consequences for the congenitally infected fetus and for patients with impaired immune systems. The challenge is to find treatment modalities that do not depend on the inhibition of the DNA replication process. This has attracted our investigation to the immediate-early (IE) stage of HCMV infection. Understanding IE1's function is our first step in the development of a practical strategy against HCMV replication via interfering with IE1 function.
In many cases, proteins play their biological role through interactions with other proteins. Especially for viral infection, viruses need to manipulate cellular function via interacting with cellular proteins. Therefore, the systematic identification and characterization of protein-protein interactions (PPIs) is considered a key strategy to understand protein function. In the case of HCMV viral immediate-early products, IE1 might be the most important protein that initiates the early interactions between the virus and cells. The number of possible contacts between protein surfaces is astronomical. In this context, protein array technology opens up new avenues for the characterization of viral proteins and the identification of molecular partners involved in virus-mediated regulatory networks in cells. The array technology used in the present study started with incubation of IE1 with the PVDF membranes that carry GST-tagged human fusion proteins. Those fusion proteins were expressed in E. coli, and after native lysis with lysozyme, crude protein extracts were prepared under non-denaturing conditions in a 384-well plate format. The crude bacterial cell extracts were used for incubation overnight with the high-density spotted PVDF membranes, which were used to detect IE1-interacting proteins.
Using the protein array, eighty-three cellular proteins in total were identified to be PPIs of HCMV IE1. Most of them were gene regulators. Only 3 IE1 PPIs from the list have been reported. However, many HCMV-mediated cell biological activities have been linked to IE1 (which link is also shown in these array assays); these activities include, among others, the interaction of IE1 with BCL-2, CDC25A, which interaction might be important for HCMV-induced "G1 arrest". Some cellular proteins reported to interact with IE1 are not on the list, they might interact with IE1 only indirectly or the printed proteins are in different isoforms. For example, some isoforms of PML was found to interact with IE1 [15] but is not on the list because the other isoforms of PML are printed on the PVDF membranes. As shown on the Table 1, 7 RNA binding proteins are found to interact with IE1, implying that IE1 has a novel function in viral mRNA processing.
In conclusion, our current effort in characterizing IE1's PPIs resulted in the identification of 83 cellular proteins that directly interact with HCMV IE1. The results have been partially validated by coIP assay. With the data listed in the Table 1 , we will further investigate the function of the PPIs of IE1.
Experimental

Tissue Culture and Viruses
The IE1-producing cell lines (U-251 MG-IE1) [29] were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS) and 1% penicillin-streptomycin.
Antibodies
The monoclonal antibody against IE1 (MAB810) and the rabbit antibodies against cellular proteins were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). The rabbit antibodies included anti-SC35 (sc-28720), -TRIM33 (sc-68424), -HDAC10 (sc-130775), and -tubulin (sc-5546). Rabbit antibodies against RBM5 (ab69970) and RBM 10 (ab126112) were bought from Abcam (Cambridge, MA, USA)
Preparation of Nuclear Extracts
Nuclear extracts were obtained essentially as described previously [15] . Briefly, monolayer cells were washed with PBS and scraped into fresh Eppendorf tubes. Cell pellets were resuspended in cold buffer A (10 mM HEPES-KOH, pH 7.9, at 4 °C, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl fluoride) and incubated for 10 min at 4 °C. Then the cells were dounced with 10-20 plunges in a Kontes-B (Wheaton, DC, USA) Dounce Homogenizer (Pestle B) and poured into new bottles after centrifugation. The pellets were resuspended in cold buffer C (20 mM HEPES-KOH, pH 7.9, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl fluoride) by vortexing and incubated for 30 min at 4 °C. The pellets were dounced again with 10-20 plunges in Kontes-B (Wheaton) Dounce Homogenizer (Pestle B), and clarified extracts were transferred to fresh tubes and stored at −70 °C until use.
Coimmunoprecipitation
Antibodies were coupled to protein G-Sepharose beads (GE Healthcare Bio-Sciences, Pittsburgh, PA, USA), according to the manufacturer's instructions. After a wash with PBS-0.1% bovine serum albumin, the beads were incubated overnight at 4 °C with clarified extracts, washed again in PBS-0.1% bovine serum albumin, and resuspended in a mixture of PBS and 2× Laemmli buffer (20 µL of each). After being heated for 5 min at 95 °C, the beads were removed by centrifugation and supernatants were analyzed by SDS-PAGE and immunoblotting.
Immunoblot Analysis
Proteins were separated by sodium dodecyl sulfate-7.5% polyacrylamide gel electrophoresis [107] (10 to 20 µg loaded in each lane), transferred to nitrocellulose membranes (Amersham Inc., Piscataway, NJ, USA), and blocked with 5% nonfat milk for 60 min at room temperature. Membranes were incubated overnight at 4 °C with primary antibody followed by incubation with a horseradish peroxidase-coupled secondary antibody (Amersham Inc.) and detection with enhanced chemiluminescence (Pierce, Rockford, IL, USA), according to standard methods. Membranes were stripped with stripping buffer (100 mM β-mercaptoethanol, 2% SDS, 62.5 mM Tris-HCl, pH 6.8), washed with PBS-0.1% Tween 20, and used to detect additional proteins.
Conclusions
We currently used a protein array assay to identify HCMV IE1 interacting proteins. 
